Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique

By Manfred Johannsen, U. Gneveckow, L. Eckelt, A. Feussner, N. Waldöfner, R. Scholz, S. Değer, Peter Wust, Stefan A. Loening, A. Jordan. International Journal of Hyperthermia, 2005

761 citations recorded by the source corpus.

Subfields: Genetics, Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/b06355d0e3758860d3142268e5f18e23a91bd732

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. I. El-Sayed
2. M. El-Sayed
3. Xiaohua Huang
4. Jon Dobson

Citations in the corpus

• Progress in applications of magnetic nanoparticles in biomedicine (2009, background): “The Jordan group have also begun clinical studies of their technology applied to the treatment of prostate cancer [61, 62], and Jordan and several of his collaborators have formed a company, MagForce Nanotechnologies AG, to commercialize the technology.”
• Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. (2008, background): “[14], and catalytic [15] properties have been exploited in the areas of cancer imaging [2,16–19], diagnostics [6,20,21], and treatment [22–30].”
• Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications (2013, background): “The same group has also began clinical studies on prostate cancer [139,140].”
• Clinical applications of magnetic nanoparticles for hyperthermia (2008, methodology): “Patients received six thermal treatments of 60 minutes duration at weekly intervals [38].”